The FOXD1 lineage of kidney perivascular cells and myofibroblasts: Functions and responses to injury

Kidney International Supplements

Volumn 4, Issue 1, 2014, Pages 26-33

  Gomez, Ivan G ^a   Duffield, Jeremy S ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b BIOGEN   (United States)

Author keywords

FOXD1 lineage; myofibroblast; pericyte

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXD1; UNCLASSIFIED DRUG;

CELL DIFFERENTIATION; CELL FATE; CELL FUNCTION; CELL LINEAGE; CELL POPULATION; GENETIC REGULATION; INFLAMMATORY CELL; KIDNEY CELL; KIDNEY DISEASE; KIDNEY INJURY; KIDNEY INTERSTITIUM; MYOFIBROBLAST; NONHUMAN; PODOCYTE; PROGENY; REVIEW;

EID: 84908544781     PISSN: 21571724     EISSN: 21571716     Source Type: Journal    
DOI: 10.1038/kisup.2014.6     Document Type: Short Survey

References (66)

1. Asada N, Takase M, Nakamura J et al. Dysfunction of fibroblasts of extrarenal origin underlies renal fibrosis and renal anemia in mice. J Clin Invest 2011; 121: 3981-3990.
2. Lin SL, Kisseleva T, Brenner DA et al. Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney. Am J Pathol 2008; 173: 1617-1627.
3. Humphreys BD, Lin SL, Kobayashi A et al. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol 2010; 176: 85-97.
4. Campanholle G, Ligresti G, Gharib SA et al. Cellular mechanisms of tissue fibrosis. Novel mechanisms of kidney fibrosis. Am J Physiol Cell Physiol 2013; 304: C591-C603.
5. Mugford JW, Sipila P, McMahon JA et al. Osr1 expression demarcates a multi-potent population of intermediate mesoderm that undergoes progressive restriction to an Osr1-dependent nephron progenitor compartment within the mammalian kidney. Dev Biol 2008; 324: 88-98.
6. Kobayashi A, Valerius MT, Mugford JW et al. Six2 defines and regulates a multipotent self-renewing nephron progenitor population throughout mammalian kidney development. Cell Stem Cell 2008; 3: 169-181.
7. Lin SL, Chang FC, Schrimpf C et al. Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis. Am J Pathol 2011; 178: 911-923.
8. Ren S, Johnson BG, Kida Y et al. LRP-6 is a coreceptor for multiple fibrogenic signaling pathways in pericytes and myofibroblasts that are inhibited by DKK-1. Proc Natl Acad Sci USA 2013; 110: 1440-1445.
9. Schrimpf C, Xin C, Campanholle G et al. Pericyte TIMP3 and ADAMTS1 modulate vascular stability after kidney injury. J Am Soc Nephrol 2012; 23: 868-883.
10. Grgic I, Duffield JS, Humphreys BD. The origin of interstitial myofibroblasts in chronic kidney disease. Pediatr Nephrol 2012; 27: 183-193.
11. Duffield JS, Humphreys BD. Origin of new cells in the adult kidney: results from genetic labeling techniques. Kidney Int 2011; 79: 494-501.
12. Rojas A, Chang FC, Lin SL et al. The role played by perivascular cells in kidney interstitial injury. Clin Nephrol 2012; 77: 400-408.
13. Duffield JS, Lupher M, Thannickal VJ et al. Host responses in tissue repair and fibrosis. Annu Rev Pathol 2013; 8: 241-276.
14. Chen YT, Chang FC, Wu CF et al. Platelet-derived growth factor receptor signaling activates pericyte-myofibroblast transition in obstructive and post-ischemic kidney fibrosis. Kidney Int 2011; 80: 1170-1181.
15. Smith SW, Schrimpf C, Parekh DJ et al. Kidney pericytes: a novel therapeutic target in interstitial fibrosis. Histol Histopathol 2012; 27: 1503-1514.
16. Humphreys BD, Valerius MT, Kobayashi A et al. Intrinsic epithelial cells repair the kidney after injury. Cell Stem Cell 2008; 2: 284-291.
17. Bielesz B, Sirin Y, Si H et al. Epithelial Notch signaling regulates interstitial fibrosis development in the kidneys of mice and humans. J Clin Invest 2010; 120: 4040-4054.
18. Endo T, Okuda T, Nakamura J et al. Exploring the origin of the cells responsible for regeneration and fibrosis in the kidney. J Am Soc Nephrol 2010; 21: F: FC163.
19. Koesters R, Kaissling B, Lehir M et al. Tubular overexpression of transforming growth factor-beta1 induces autophagy and fibrosis but not mesenchymal transition of renal epithelial cells. Am J Pathol 2010; 177: 632-643.
20. Kriz W, Kaissling B, Le Hir M. Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy? J Clin Invest 2011; 121: 468-474.
21. Scholten D, Osterreicher CH, Scholten A et al. Genetic labeling does not detect epithelial-to-mesenchymal transition of cholangiocytes in liver fibrosis in mice. Gastroenterology 2010; 139: 987-998.
22. Rock JR, Barkauskas CE, Cronce MJ et al. Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition. Proc Natl Acad Sci USA 2011; 108: E1475-E1483.
23. Rock JR, Hogan BL. Epithelial progenitor cells in lung development, maintenance, repair, and disease. Ann Rev Cell Dev Biol 2011; 27: 493-512.
24. Hung C, Linn G, Chow YH et al. Role of lung pericytes and resident fibroblasts in the pathogenesis of pulmonary fibrosis. Am J Respir Crit Care Med 2013; 188: 820-830.
25. Friedman SL, Sheppard D, Duffield JS et al. Therapy for fibrotic diseases: nearing the starting line. Sci Transl Med 2013; 5: sr161.
26. Yang L, Besschetnova TY, Brooks CR et al. Epithelial cell cycle arrest in G2/ M mediates kidney fibrosis after injury. Nat Med 2010; 16: 535-543, 531 page following 143.
27. Gomez IG, MacKenna D, Roach AM et al. Anti-miR21 protects collagen 4A3 deficient mice from progression of alport disease by decreasing oxidative stress. J Am Soc Nephrol 2013; 24: 93A.
28. Piera-Velazquez S, Li Z, Jimenez SA. Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders. Am J Pathol 2011; 179: 1074-1080.
29. Zeisberg EM, Potenta S, Xie L et al. Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. Cancer Res 2007; 67: 10123-10128.
30. Zeisberg EM, Potenta SE, Sugimoto H et al. Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J Am Soc Nephrol 2008; 19: 2282-2287.
31. Chang L, Noseda M, Higginson M et al. Differentiation of vascular smooth muscle cells from local precursors during embryonic and adult arteriogenesis requires Notch signaling. Proc Natl Acad Sci USA 2012; 109: 6993-6998.
32. Ligresti G, Aburante T, Sun S et al. Development of the kidney peritubular microvascular niche ex vivo. J Am Soc Nephrol 2013; 24: 142A.
33. LeBleu VS, Taduri G, O'Connell J et al. Origin and function of myofibroblasts in kidney fibrosis. Nat Med 2013; 19: 1047-1053.
34. Lin SL, Castano AP, Nowlin BT et al. Bone marrow Ly6Chigh monocytes are selectively recruited to injured kidney and differentiate into functionally distinct populations. J Immunol 2009; 183: 6733-6743.
35. Reich B, Schmidbauer K, Rodriguez Gomez M et al. Fibrocytes develop outside the kidney but contribute to renal fibrosis in a mouse model. Kidney Int 2013; 84: 78-89.
36. Gomez I, Nakagawa N, Roach A et al. Myeloid lineage leukocytes retain lineage boundaries in models of kidney disease. J Am Soc Nephrol 2013; 24: 184A.
37. Ammerpohl O, Schmitz A, Steinm ller L et al. Repression of the mouse M-lysozyme gene involves both hindrance of enhancer factor binding to the methylated enhancer and histone deacetylation. Nucleic Acids Res 1998; 26: 5256-5260.
38. Clausen BE, Burkhardt C, Reith W et al. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res 1999; 8: 265-277.
39. Dulauroy S, Di Carlo SE, Langa F et al. Lineage tracing and genetic ablation of ADAM12(+) perivascular cells identify a major source of profibrotic cells during acute tissue injury. Nat Med 2012; 18: 1262-1270.
40. Abe R, Donnelly SC, Peng T et al. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol 2001; 166: 7556-7562.
41. Bucala R, Spiegel LA, Chesney J et al. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1994; 1: 71-81.
42. Cohnheim JF. Ueber Entzuendung und Eiterung. Virchows Arch Path Anat Physiol Klin Med 1867; 40: 1-79.
43. Kida Y, Ieronimakis N, Schrimpf C et al. EphrinB2 reverse signaling protects against capillary rarefaction and fibrosis after kidney injury. J Am Soc Nephrol 2013; 24: 559-572.
44. Fabian SL, Penchev RR, St-Jacques B et al. Hedgehog-Gli pathway activation during kidney fibrosis. Am J Pathol 2012; 180: 1441-1453.
45. Wu CF, Chiang WC, Lai CF et al. Transforming growth factor beta-1 stimulates profibrotic epithelial signaling to activate pericytemyofibroblast transition in obstructive kidney fibrosis. Am J Pathol 2013; 182: 118-131.
46. He W, Dai C, Li Y et al. Wnt/beta-catenin signaling promotes renal interstitial fibrosis. J Am Soc Nephrol 2009; 20: 765-776.
47. Ding H, Zhou D, Hao S et al. Sonic hedgehog signaling mediates epithelial-mesenchymal communication and promotes renal fibrosis. J Am Soc Nephrol 2012; 23: 801-813.
48. Smith SW, Eardley KS, Croft AP et al. CD248+ stromal cells are associated with progressive chronic kidney disease. Kidney Int 2011; 80: 199-207.
49. Grgic I, Krautzberger M, Hofmeister A et al. Translational profiles of medullary myofibroblasts during kidney fibrosis. J Am Soc Nephrol 2014; 25: 1979-1990.
50. Li SW, Arita M, Fertala A et al. Transgenic mice with inactive alleles for procollagen N-proteinase (ADAMTS-2) develop fragile skin and male sterility. Biochem J 2001; 355: 271-278.
51. Wang WM, Ge G, Lim NH et al. TIMP-3 inhibits the procollagen N-proteinase ADAMTS-2. Biochem J 2006; 398: 515-519.
52. Jacob M, Chang L, Pure E. Fibroblast activation protein in remodeling tissues. Curr Mol Med 2012; 12: 1220-1243.
53. Takeshita S, Fumoto T, Matsuoka K et al. Osteoclast-secreted CTHRC1 in the coupling of bone resorption to formation. J Clin Invest 2013; 123: 3914-3924.
54. Kyriakides TR, Zhu YH, Yang Z et al. Altered extracellular matrix remodeling and angiogenesis in sponge granulomas of thrombospondin 2-null mice. Am J Pathol 2001; 159: 1255-1262.
55. Nakagawa N, Roach A, Gomez IG et al. MicroRNAs are critical regulators of FOXD1 progenitors and kidney stroma during nephrogenesis. J Am Soc Nephrol 2013; 25: 184A.
56. Nourshargh S, Hordijk PL, Sixt M. Breaching multiple barriers: leukocyte motility through venular walls and the interstitium. Nat Rev Mol Cell Biol 2010; 11: 366-378.
57. Proebstl D, Voisin MB, Woodfin A et al. Pericytes support neutrophil subendothelial cell crawling and breaching of venular walls in vivo. J Exp Med 2012; 209: 1219-1234.
58. Voisin MB, Nourshargh S. Neutrophil transmigration: emergence of an adhesive cascade within venular walls. J Innate Immun 2013; 5: 336-347.
59. Campanholle G, Mittelsteadt K, Nakagawa S et al. TLR-2/TLR-4 TREM-1 signaling pathway is dispensable in inflammatory myeloid cells during sterile kidney injury. PloS One 2013; 8: e68640.
60. Nakagawa S, Lichtnekert J, Campanholle G et al. Pericytes are critical innate immune response sentinels in the kidney. J Am Soc Nephrol 2013; 24: 499A.
61. Bechtel W, McGoohan S, Zeisberg EM et al. Methylation determines fibroblast activation and fibrogenesis in the kidney. Nat Med 2010; 16: 544-550.
62. Levinson RS, Batourina E, Choi C et al. Foxd1-dependent signals control cellularity in the renal capsule, a structure required for normal renal development. Development 2005; 132: 529-539.
63. Brunskill EW, Georgas K, Rumballe B et al. Defining the molecular character of the developing and adult kidney podocyte. PloS One 2011; 6: e24640.
64. Jin J, Sison K, Li C et al. Soluble FLT1 binds lipid microdomains in podocytes to control cell morphology and glomerular barrier function. Cell 2012; 151: 384-399.
65. Abrahamson DR, Hudson BG, Stroganova L et al. Cellular origins of type IV collagen networks in developing glomeruli. J Am Soc Nephrol 2009; 20: 1471-1479.
66. Smeets B, Kuppe C, Sicking EM et al. Parietal epithelial cells participate in the formation of sclerotic lesions in focal segmental glomerulosclerosis. J Am Soc Nephrol 2011; 22: 1262-1274.